ClinVar Miner

Submissions for variant NM_153766.3(KCNJ1):c.1013T>C (p.Met338Thr)

gnomAD frequency: 0.00742  dbSNP: rs59172778
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia RCV000202885 SCV000258256 benign not specified 2015-06-08 criteria provided, single submitter clinical testing
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics RCV000224891 SCV000280824 benign not provided 2015-11-24 criteria provided, single submitter clinical testing
Invitae RCV000224891 SCV001121924 benign not provided 2024-01-31 criteria provided, single submitter clinical testing
GeneDx RCV000224891 SCV001950571 benign not provided 2021-05-05 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 9580661, 20981092, 8841184, 27884173, 12589089, 28492530, 29191167)
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000202885 SCV002103405 likely benign not specified 2022-02-18 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003914824 SCV004734238 benign KCNJ1-related disorder 2019-09-26 criteria provided, single submitter clinical testing This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Molecular Genetics, Royal Melbourne Hospital RCV000009728 SCV004812382 benign Bartter disease type 2 2023-05-04 criteria provided, single submitter clinical testing European Non-Finnish population allele frequency is 1.112% (rs59172778, 1491/129090 alleles, 14 homozygotes in gnomAD v2.1). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.5.1, this variant is classified as BENIGN. Following criteria are met: BA1
OMIM RCV000009728 SCV000029949 pathogenic Bartter disease type 2 1996-10-01 no assertion criteria provided literature only
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV000224891 SCV001932041 likely benign not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000202885 SCV001973324 benign not specified no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.